EUVIMEDEUVIMED entdecken
Crossref

Exploration of Drugs Associated With the Development of Bullous Pemphigoid: A Nationwide Study

Min Jae Kim iD, Bo Ri Kim iD, Kun Hee Lee, Hyun Jeong Ju, Jung Min Bae, Chong Won Choi, Sang Woong Youn

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Min Jae Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Pemphigoid, Bullous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Seoul National University Bundang Hospital Research Fund, National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIT), Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid (BP) is an autoimmune blistering skin disorder with an increasing incidence, particularly among older adults. Given the role of medications in developing drug‐associated BP (DABP), exploring drugs that cause DABP is crucial for prescribing appropriate drugs to prevent BP development. This study aimed to identify drugs associated with DABP. In this nationwide retrospective cohort study, we compared 5066 patients newly diagnosed with BP with 10 132 matched controls. We first established a comprehensive drug list of all medications used in our country and conducted a case–control study to identify candidate drugs associated with DABP. To validate these associations, we performed a separate cohort study, enrolling patients with a confirmed diagnosis of BP and matched controls. In the screening stage, 88 drugs were associated with an increased risk of DABP, while 27 drugs were linked with a reduced risk. Validation confirmed that 78 drugs increased the risk of DABP, whereas 22 drugs lowered it. Among the candidate drugs, anti‐diabetic medications, including dipeptidyl peptidase‐4 (DPP4) inhibitors and sulfonylureas, neuropsychiatric drugs such as benserazide and carbidopa (used for Parkinson's disease) and donepezil and memantine (for Alzheimer's disease), increased the risk of DABP. Conversely, several anti‐inflammatory medications, including meloxicam and celecoxib and lipid‐lowering agents, such as rosuvastatin and atorvastatin, have been found to lower the risk of DABP. Lastly, diazepam, diltiazem, and Ginkgo biloba extracts exhibited protective effects against DABP development. This nationwide study, employing an unbiased analysis of all medications in our country, highlights a substantial number of medications linked to the development of DABP. Our study provides practical insights for drug selection to prevent the development of DABP in elderly patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousHumansMaleAgedFemaleRetrospective StudiesCase-Control StudiesAged, 80 and overMiddle AgedHypoglycemic AgentsDipeptidyl-Peptidase IV Inhibitors

Stichwörter der Autor:innen

autoimmune bullous skin diseasesbullous pemphigoidcase–control studydrugpharmacovigilance

Substanzen

Hypoglycemic AgentsDipeptidyl-Peptidase IV Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Applied Statistics, Yonsei University, Seoul, Korea.
  • Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Min Jae Kim, Bo Ri Kim

Förderung

  • Seoul National University Bundang Hospital Research Fund
  • National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIT)
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Kim, M. J., Kim, B. R., Lee, K. H., Ju, H. J., Bae, J. M., Choi, C. W., & Youn, S. W. (2025). Exploration of Drugs Associated With the Development of Bullous Pemphigoid: A Nationwide Study. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17809

Vancouver

Kim MJ, Kim BR, Lee KH, Ju HJ, Bae JM, Choi CW, et al. Exploration of Drugs Associated With the Development of Bullous Pemphigoid: A Nationwide Study. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17809

BibTeX
@article{Kim2025,
  author = {Kim, Min Jae and Kim, Bo Ri and Lee, Kun Hee and Ju, Hyun Jeong and Bae, Jung Min and Choi, Chong Won and Youn, Sang Woong},
  title = {Exploration of Drugs Associated With the Development of Bullous Pemphigoid: A Nationwide Study},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17809}
}
Kostenlos starten →